A highly efficient method and system for extracting Gastrodia elata exosome-like nanovesicles

By employing physical crushing and tangential flow ultrafiltration technologies, the problems of low extraction efficiency and low purity of Gastrodia elata exosomes have been solved, enabling efficient and low-cost large-scale production of Gastrodia elata exosomes, which is suitable for the large-scale production of functional exosomes.

CN123107900APending Publication Date: 2026-11-17浙江省人民医院毕节医院
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510636772.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-17
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing technologies, the extraction efficiency of Gastrodia elata exosomes is low, the purity is not high, and the cost is high, making it difficult to meet the needs of large-scale production and research.

Method used

By employing physical disruption combined with high-speed separation and specific purification techniques, including low-temperature disruption, tangential flow ultrafiltration, and multi-stage membrane filtration, along with nano-laser particle size and potential detection, efficient extraction of Gastrodia elata exosomes is achieved.

Benefits of technology

High-purity exosomes from Gastrodia elata were extracted efficiently and at low cost. The particle size was concentrated at 71 nm, the concentration was 4.43 × 10¹¹ particles/mL, and the potential was -3.50 to -6.48 mV, which is suitable for large-scale production of functional exosomes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

This invention belongs to the field of biomedical technology, specifically relating to a highly efficient extraction method for Gastrodia elata exosome-like nanovesicles (GELNVs) suitable for industrial production. The method includes the following steps: Step 1: Gastrodia elata tubers are rapidly washed and then crushed and juiced at low temperature; Step 2: The juiced liquid is collected and centrifuged at 8500 rpm, 4℃, for 90 min, the supernatant is collected, and the precipitate is removed. This process is repeated twice; Step 3: The supernatant after removing the precipitate is sequentially filtered through 0.45 μm and 0.22 μm fiber microporous membranes; Step 4: The filtered liquid is collected and concentrated and purified using tangential flow ultrafiltration (TFF, 750 kDa hollow fiber column, TMP = 4 psi, flow rate 300 mL / min); Step 5: The nanovesicles are analyzed by a nanolaser particle size analyzer to obtain a particle size of 55-156 nm and a concentration of 4.43 × 10⁻⁶. 11 GELNVs were measured in particles / mL. Step six: The zeta potential was measured using a dynamic light scattering instrument (Malvin, Zetasizer Nano 25) and found to be -3.50 to -6.48 mV. Using Gastrodia elata tubers as raw material, the extracted GELNVs exhibit excellent stability after freeze-drying and can be directly used in the industrial production of oral tablets or capsules. Furthermore, compared to traditional ultracentrifugation, this invention innovatively optimizes the TFF (tangential flow filtration) process parameters, eliminating reliance on ultracentrifugation equipment. While ensuring processing efficiency, it effectively reduces energy consumption and production costs, achieving a significant improvement in process economics.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biotechnology, specifically relating to a method and supporting system for the efficient extraction of exosomes from the medicinal plant Gastrodia elata, which is applicable to the development of natural drugs and the large-scale production of functional exosomes. Background Technology

[0002] Extracellular vesicles (EVs) are lipid-bound vesicles secreted by cells into the extracellular space. The three main subtypes of EVs are microvesicles (MVs), exosomes, and apoptotic bodies, distinguished by their biogenesis, release pathway, size, contents, and function. The contents, or "cargo," of EVs consist of lipids, nucleic acids, and proteins—particularly proteins associated with the plasma membrane and cytoplasm, as well as proteins involved in lipid metabolism. They hold appeal as potential disease biomarkers and therapeutics in biotechnology and biomedical research. A key to realizing this potential is the ability to manufacture high-quality exosomes; however, unlike biopharmaceuticals such as proteins, the processing and characterization of exosomes lack standardized good manufacturing practices. Furthermore, there is a lack of well-characterized reference exosome materials to aid in the selection of methods for exosome isolation, purification, and analysis.

[0003] In recent years, research on animal-derived exosomes has made rapid progress, but research on plant-derived exosomes is relatively insufficient.

[0004] Insufficient development of plant exosomes:

[0005] 1. Although plant exosomes (such as ginger and grapefruit) have advantages such as low immunogenicity and high biocompatibility, their extraction methods (such as differential centrifugation combined with ultrafiltration) have low yields (<0.5 mg / kg fresh weight), and the plant cell wall hinders the release of exosomes, resulting in the loss of active ingredients.

[0006] 2. Research on exosomes of traditional medicinal plants (such as Gastrodia elata) is almost nonexistent. Gastrodin is the main active ingredient of Gastrodia elata and has anti-inflammatory and neuroprotective effects, but its oral bioavailability is low (<5%), making it difficult to effectively target joint tissues.

[0007] Limitations of existing extraction methods:

[0008] 1. Low extraction efficiency: Traditional exosome extraction methods, such as ultracentrifugation, require long centrifugation operations and are cumbersome. For substances like Gastrodia elata exosome nanovesicles, which have relatively low content, the efficiency is low, making it difficult to obtain a sufficient amount of sample for research and application in a short period of time.

[0009] 2. Low purity: Some commonly used extraction methods may leave impurities, affecting subsequent component analysis and functional studies of Gastrodia elata exosome nanovesicles. For example, precipitation methods may precipitate some non-exosome proteins and nucleic acids, reducing the purity of the extract.

[0010] 3. High cost: Some extraction techniques, such as immunoaffinity assays, can obtain exosomes with high purity, but they require expensive antibodies, resulting in high costs and making them unsuitable for large-scale production and application.

[0011] This invention is the first to propose a technique for efficiently extracting exosome nanovesicles from Gastrodia elata using tangential flow ultrafiltration technology. Summary of the Invention

[0012] Objective: To provide an efficient, low-cost, and high-purity method for extracting exosomes from Gastrodia elata, combining physical disruption, high-speed separation, and specific purification techniques.

[0013] To achieve the above objectives, the present invention provides the following solution:

[0014] Methods for extracting exosomes from Gastrodia elata include:

[0015] Step 1: Gastrodia elata is quickly washed and then crushed and juiced at low temperature; Step 2: The crushed and juiced liquid is collected and subjected to two separate processes at 8500 rpm, 4℃, and 90 min to remove impurities and precipitates; Step 3: The supernatant after removing precipitates is sequentially passed through 0.45 μm and 0.22 μm fiber microporous membranes; Step 4: The filtered liquid is collected and concentrated and purified into nanovesicles using tangential flow ultrafiltration (TFF, 750 kDa hollow fiber column, TMP = 4 psi, flow rate 300 mL / min);

[0016] Step 5: The particle size was measured using a nano-laser particle size analyzer, yielding particles with a diameter of 55-156 nm and a concentration of 4.43 × 10⁻⁶ nm. 11 GELNVs particles / mL. Step 6: The Zeta potential was obtained by dynamic light scattering instrumentation, ranging from -3.50 to -6.48 mV.

[0017] The present invention discloses the following technical effects:

[0018] The exosomes extracted by this invention exhibit a teacup-like membrane vesicle structure, with a particle size concentrated around 71 nm. This invention provides a convenient and efficient method for extracting exosome nanovesicles from Gastrodia elata. Attached Figure Description

[0019] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0020] Figure 1 This is a flowchart of the gastrodia elata exosome extraction process of the present invention;

[0021] Figure 2 This is a graph showing the concentration and particle size distribution of the Gastrodia elata exosomes extracted in this invention;

[0022] Figure 3 This is a Zeta potential map of the Gastrodia elata exosomes extracted in this invention;

[0023] Figure 4 This is a transmission electron microscope image of the exosomes extracted from Gastrodia elata in this invention; Detailed Implementation

[0024] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0025] The terminology used in this invention is for describing specific embodiments only and is not intended to limit the invention. Regarding numerical ranges in this invention, it should be understood that every intermediate value between the upper and lower limits of the range has been specifically disclosed. Any stated value or intermediate value within a range, as well as smaller ranges between these intermediate values, are within the scope of this invention. The upper and lower limits of these smaller ranges may be independently selected to be included or excluded from the range.

[0026] Unless otherwise expressly stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although only preferred methods and materials are described herein, any similar or equivalent methods and materials may be used in practice or testing. All references cited in this specification are incorporated by way of reference to disclose and describe related methods and / or materials. In the event of any conflict with cited references, the content of this specification shall prevail.

[0027] Without departing from the scope and core spirit of this invention, the specific embodiments described in this specification can be optimized and adjusted in various ways, and these improvements are obvious to those skilled in the art. Other embodiments derived from this specification are also easily understood by those skilled in the art. Therefore, this specification and embodiments are for illustrative purposes only. The terms "comprising," "including," "having," "containing," etc., used herein are open-ended terms, meaning that they include but are not limited to.

[0028] Example 1: Extraction of Gastrodia elata exosomes

[0029] Methods for extracting exosomes from Gastrodia elata:

[0030] 1. See Figure 1 The extraction process shown involves taking fresh Gastrodia elata tubers, washing and peeling them, and then drying them.

[0031] 2. After drying, extract the gastrodia elata juice using a fresh juicer. Centrifuge the gastrodia elata juice at 8500 rpm, 4℃, and 90 min. After centrifugation, collect the supernatant and discard the precipitate. Repeat this step twice.

[0032] 3. Filter the obtained supernatant sequentially using a 0.45μm filter (Shanghai Xinya, 50mm*0.45μm) and a 0.22μm filter (Shanghai Xinya, 50mm*0.22μm), and collect the filtrate;

[0033] 4. The filtered liquid was collected and concentrated and purified by tangential flow ultrafiltration (TFF, 750 kDa hollow fiber column, TMP = 4 psi, flow rate 300 mL / min);

[0034] 5. Measure the particle size of the extracted Gastrodia elata exosomes. Dilute the exosomes with phosphate buffer at a ratio of 1:1000, mix well, and take 200 μL into a dedicated chip for detection. The results are as follows: Figure 2 As shown, the exosomes are mainly concentrated around 71 nm in size, falling within the exosome size range (30-200 nm). The concentration is 4.43 × 10⁻⁶. 11 GELNVs particles / mL.

[0035] 6. Measure the potential of the extracted Gastrodia elata exosomes. Add 1 ml of the exosome solution to the Malvern potential sample cell for detection. The results are as follows: Figure 3 As shown, the Zeta potential of exosomes is -3.50 to...

[0036] -6.48mV.

[0037] 7. The extracted Gastrodia elata exosomes were observed under a transmission electron microscope (TEM) as follows: 20 μL of Gastrodia elata exosomes were pipetted and evenly dropped onto a carbon film copper grid. The mixture was left to stand for 3 minutes, then excess liquid was blotted away with filter paper. The mixture was stained with 2% phosphotungstic acid for 2 minutes, dried at room temperature, and then observed under a TEM. Images were acquired and analyzed. Results are as follows: Figure 4 As shown, the exosomes extracted in this invention are mostly teacup-like membrane vesicle structures with clear membranes in the electron microscope field.

[0038] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Various modifications and improvements made by those skilled in the art to the technical solutions of the present invention without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.

Claims

1. A convenient and efficient method for extracting exosomes from Gastrodia elata.

2. The application according to claim 1, characterized in that, The method for extracting Gastrodia elata exosomes includes: After rapid washing, the Gastrodia elata tubers were crushed and juiced at low temperature. The collected liquid was separated, and the supernatant was collected. The precipitate was removed, and this step was repeated twice. The collected supernatant was then filtered sequentially through 0.45μm and 0.22μm fiber microporous membranes using negative pressure filtration. The precipitate was then removed using tangential flow ultrafiltration technology to obtain the Gastrodia elata exosomes.

3. The application according to claim 2, characterized in that, The elution conditions were: 8500 rpm, 4℃, 90 min; supernatant collected; precipitate discarded; repeat twice. The precipitate was resuspended in PBS buffer and filtered through 0.45 μm and 0.22 μm membranes. Tangential flow ultrafiltration conditions were: TFF, 750 kDa hollow fiber column, TMP = 4 psi, flow rate 300 mL / min.

4. The efficient extraction method for Gastrodia elata exosome-like nanovesicles according to claim 2, characterized in that, The tangential flow ultrafiltration system described in step four has a single batch processing capacity of 2 kg of Gastrodia elata tubers, and unlike traditional extraction methods, it does not require ultracentrifugation equipment.

5. A GELNVs extracted by the method described in claim 2, characterized in that, Its particle size ranges from 55 to 156 nm, and its zeta potential is -3.50 to -6.48 mV.